Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

Case of an acute retroviral disease

Maciej M. Kowalik, Hanna Trocha, Małgorzata Lemańska

Med Sci Monit 1998; 4(4): CS720-723 :: ID: 470770


An acute retoviral disease under the form of a mononucleosis-like syndrome 14 to 60 days following an HIV infection is rarely observed. . The case presented, concerns a 32 year old woman, sexually active with a seropositive male. She was admitted to our clinic due to 6 weeks of general weakness, fever of 39¡ C and musculo-articular pains. The physical examination revealed anemia, a palmar rubella- like rash, generalized lymphadenopathy, hepatomegaly and whitish deposits on the buccal mucosa. Biochemical parameters revealed: an increased erythrocyte sedimentation rate, the presence of atypical lymphocytes, thrombocytopenia and a rise in AlAT titers. The Paul-Bunnell-Davidson reaction test was positive. Serologic tests towards HAV, HBV, HCV, CMV and toxoplasmosis turned out negative. The epidemiologic history and clinical picture obliged us to perform the ELISA test for the presence of HIV antibodies. We performed the test twice receiving positive dubious results. A positive Western-blot test (8 weeks from exposition) confirmed our diagnosis. The lymphocytic subpopulation test revealed the presence of CD4 lymphocytes- 520/mm3, CD8 lymphocytes-3420mm3 and the CD4/CD8 ratio of 0.2. We noted hypergammaglobulinemia. Following the patients consent we started therapy with zidovudine (AZT) at a dose of 500 mg per day. After 5 days of hospitalization, following
the remission of acute symptoms, the patient was discharged home.
During the following 7 months of ambulatory observation, the woman presented lymphadenopathy buccal and vaginal mycosis, leucopenia, an increased erythrocyte sedimentation rate, hypergammaglobulinemia, reduction of the CD4 subpopulation and a decreased CD4 /CD8 ratio. The epidemiological history confirmed our preliminary diagnosis.

Keywords: retroviral disease

Add Comment 0 Comments


01 May 2024 : Editorial  

Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)

Dinah V. Parums

DOI: 10.12659/MSM.944927

Med Sci Monit 2024; 30:e944927

In Press

Clinical Research  

The Influence of Gestational Diabetes Mellitus on Maternal and Neonatal Outcomes: A Retrospective Study in ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943644  


Clinical Research  

Exploring the Educational Social and Physical Activities Among Health Care Undergraduates – a Cross-Section...

Med Sci Monit In Press; DOI: 10.12659/MSM.943399  


Clinical Research  

Percutaneous Coronary Intervention as a Non-Surgical Treatment for Ischemic Mitral Regurgitation in Patient...

Med Sci Monit In Press; DOI: 10.12659/MSM.943122  

Clinical Research  

Maxillary Canine Impaction: Assessing the Influence of Maxillary Anatomy Using Cone Beam Computed Tomography

Med Sci Monit In Press; DOI: 10.12659/MSM.944306  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799


14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990


16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387


01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952


Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750